Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Adam Crystal currently holds 395,040 shares of C4 Therapeutics, Inc. (CCCC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Adam Crystal has been a net seller of CCCC stock. They have purchased $0 and sold $5.6M worth of shares.
Adam Crystal's most recent insider trade was on Apr 15, 2026, when they sold 38,460 shares at $0.00 per share.
Adam Crystal serves as Executive at C4 Therapeutics, Inc. (CCCC). They have executed 37 insider transactions totaling $5.6M over their tenure at the company.
Adam Crystal holds the position of Executive at C4 Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Adam Crystal has shown a selling trading pattern, with $0 in total purchases and $5.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Adam Crystal was on Apr 15, 2026, when they sold $961.5K worth of TNGX shares. This transaction involved 38,460 shares at $25.00 per share.
Adam Crystal currently owns 395,040 shares of C4 Therapeutics, Inc. (CCCC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Adam Crystal's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Adam Crystal has 37 Form 4 filings on record as an insider at C4 Therapeutics, Inc..
Set alerts for Adam Crystal and 40,000+ other insiders.